Field | Row 1 |
---|---|
adsh | 0001213900-25-045434 |
cik | 1769768 |
name | E-HOME HOUSEHOLD SERVICE HOLDINGS LTD |
sic | 7600 |
countryba | CN |
stprba | |
cityba | CANGSHAN DISTRICT, FUZHOU CITY |
zipba | 350001 |
bas1 | FLOOR 9, BUILDING 14, HAIXIBAIYUE TOWN |
bas2 | HEYUAN ROAD, LUZHOU TOWN |
baph | 86-591-87590668 |
countryma | CN |
stprma | |
cityma | CANGSHAN DISTRICT, FUZHOU CITY |
zipma | 350001 |
mas1 | FLOOR 9, BUILDING 14, HAIXIBAIYUE TOWN |
mas2 | HEYUAN ROAD, LUZHOU TOWN |
countryinc | KY |
stprinc | |
ein | 000000000 |
former | |
changed | |
afs | 4-NON |
wksi | 0 |
fye | 0630 |
form | 6-K |
period | 20241231 |
fy | 2024 |
fp | Q2 |
filed | 20250519 |
accepted | 2025-05-19 16:30:00.0 |
prevrpt | 0 |
detail | 0 |
instance | ea0239579-6k_ehome_htm.xml |
nciks | 1 |
aciks |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
countryba | The ISO 3166-1 country of the registrant's business address. |
stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
cityba | The city of the registrant's business address. |
zipba | The zip code of the registrant’s business address. |
bas1 | The first line of the street of the registrant’s business address. |
bas2 | The second line of the street of the registrant’s business address. |
baph | The phone number of the registrant’s business address. |
countryma | The ISO 3166-1 country of the registrant's mailing address. |
stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
cityma | The city of the registrant's mailing address. |
zipma | The zip code of the registrant’s mailing address. |
mas1 | The first line of the street of the registrant’s mailing address. |
mas2 | The second line of the street of the registrant’s mailing address. |
countryinc | The ISO 3166-1 country of incorporation for the registrant. |
stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
former | Most recent former name of the registrant, if any. |
changed | Date of change from the former name, if any. |
afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
fye | Fiscal Year End Date, rounded to nearest month-end. |
form | The submission type of the registrant’s filing. |
period | Balance Sheet Date, rounded to nearest month-end. |
fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
filed | The date of the registrant’s filing with the Commission. |
accepted | The acceptance date and time of the registrant’s filing with the Commission. |
prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
---|---|---|---|---|---|---|---|---|---|
0001213900-25-045434 | 20240630 | Liabilities | 15561047.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Deferred Income Tax Liabilities Net | 1819826.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Accounts Payable And Accrued Liabilities Current | 7281276.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Accounts Payable And Accrued Liabilities Current | 6858696.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | -8024380.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Amortization Of Financing Costs | 623801.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Cash And Cash Equivalents At Carrying Value | 132240950.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Contract With Customer Liability Current | 501890.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Cost Of Revenue | 11201726.0000 | USD | 2 | us-gaap/2024 | Product Or Service= Maintenance; | ||
0001213900-25-045434 | 20231231 | Earnings Per Share Basic | -19.6200 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Earnings Per Share Basic | -0.9500 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -765098.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Equity Incentive Plan | 327340.0000 | USD | 2 | 0001213900-25-045434 | |||
0001213900-25-045434 | 20231231 | Income Tax Expense Benefit | USD | 2 | us-gaap/2024 | ||||
0001213900-25-045434 | 20231231 | Increase Decrease In Contract With Customer Liability | -628531.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Increase Decrease In Other Noncurrent Assets | -2014298.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -4143426.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Increase Decrease In Prepaid Supplies | -944315.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Investment Income Interest | 127142.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Investment Income Interest | 178181.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Liabilities Current | 12427945.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Net Cash Provided By Used In Investing Activities | -10688160.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Net Cash Provided By Used In Operating Activities | 1381424.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Net Income Loss Attributable To Noncontrolling Interest | 23601.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Net Income Loss Attributable To Noncontrolling Interest | USD | 2 | us-gaap/2024 | ||||
0001213900-25-045434 | 20241231 | Operating Income Loss | -5224774.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -5949.0000 | USD | 2 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
0001213900-25-045434 | 20231231 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | USD | 2 | us-gaap/2024 | Equity Components= Statutory Reserve; | |||
0001213900-25-045434 | 20241231 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -856181.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | USD | 2 | us-gaap/2024 | Equity Components= Statutory Reserve; | |||
0001213900-25-045434 | 20241231 | Payments To Acquire Loans Receivable | 31930000.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Proceeds From Issuance Of Common Stock | 12001420.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Proceeds From Repayments Of Related Party Debt | 20662.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Property Plant And Equipment Net | 4128751.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Revenue From Contract With Customer Including Assessed Tax | 7836579.0000 | USD | 2 | us-gaap/2024 | Product Or Service= Housekeeping; | ||
0001213900-25-045434 | 20230630 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 664100.0000 | USD | 0 | us-gaap/2024 | Equity Components= Statutory Reserve; | ||
0001213900-25-045434 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 307.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001213900-25-045434 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 664100.0000 | USD | 0 | us-gaap/2024 | Equity Components= Statutory Reserve; | ||
0001213900-25-045434 | 20231231 | Stock Issued During Period Shares Conversion Of Convertible Securities | 33490.0000 | shares | 2 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001213900-25-045434 | 20231231 | Stock Issued During Period Value Conversion Of Convertible Securities | 3480679.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Stock Issued During Period Value Conversion Of Convertible Securities | USD | 2 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
0001213900-25-045434 | 20241231 | Stock Issued During Period Value Disposal Of Equity | 5731103.0000 | USD | 2 | 0001213900-25-045434 | |||
0001213900-25-045434 | 20241231 | Stock Issued During Period Value Disposal Of Equity | 6546925.0000 | USD | 2 | 0001213900-25-045434 | Equity Components= Retained Earnings; | ||
0001213900-25-045434 | 20231231 | Stock Issued During Period Value New Issues | 9855079.0000 | USD | 2 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001213900-25-045434 | 20231231 | Stock Issued During Period Value New Issues | USD | 2 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | |||
0001213900-25-045434 | 20231231 | Stock Issued During Period Value New Issues | USD | 2 | us-gaap/2024 | Equity Components= Statutory Reserve; | |||
0001213900-25-045434 | 20241231 | Stock Issued During Period Value New Issues | USD | 2 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | |||
0001213900-25-045434 | 20241231 | Stock Issued During Period Value New Issues | USD | 2 | us-gaap/2024 | Equity Components= Statutory Reserve; | |||
0001213900-25-045434 | 20241231 | Stock Issued During Period Value Reverse Stock Split | -146.0000 | USD | 2 | 0001213900-25-045434 | Equity Components= Additional Paid In Capital; | ||
0001213900-25-045434 | 20241231 | Weighted Average Number Of Diluted Shares Outstanding | 8402293.0000 | shares | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Increase Decrease In Other Noncurrent Assets | -350833.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Accounts Receivable Net Current | 464416.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Accumulated Other Comprehensive Income Loss Net Of Tax | -7168199.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Common Stock Shares Outstanding | 8690171.0000 | shares | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Cost Of Revenue | 20371994.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Cost Of Revenue | 1719011.0000 | USD | 2 | us-gaap/2024 | Product Or Service= Senior Care Services; | ||
0001213900-25-045434 | 20241231 | Cost Of Revenue | 12510940.0000 | USD | 2 | us-gaap/2024 | Product Or Service= Maintenance; | ||
0001213900-25-045434 | 20241231 | Finite Lived Intangible Assets Net | 831.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | General And Administrative Expense | 2786747.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Gross Profit | 6575189.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Income Taxes Paid | USD | 2 | us-gaap/2024 | ||||
0001213900-25-045434 | 20231231 | Increase Decrease In Accounts Payable And Accrued Liabilities | -1171817.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Issuance Of Shares To Directors And Consultants | 327340.0000 | USD | 2 | 0001213900-25-045434 | |||
0001213900-25-045434 | 20240630 | Liabilities Noncurrent | 3133102.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Net Income Loss | USD | 2 | us-gaap/2024 | Equity Components= Statutory Reserve; | |||
0001213900-25-045434 | 20241231 | Operating Lease Liability Current | 77193.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Operating Lease Liability Noncurrent | 1313276.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | 687989.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | USD | 2 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
0001213900-25-045434 | 20241231 | Proceeds From Issuance Of Common Stock | 65000257.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Profit Loss | -5169892.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Repayments Of Convertible Debt | USD | 2 | us-gaap/2024 | ||||
0001213900-25-045434 | 20241231 | Revenue From Contract With Customer Including Assessed Tax | 26372068.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 162814934.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001213900-25-045434 | 20240630 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 191883857.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001213900-25-045434 | 20241231 | Stock Issued During Period Value Disposal Of Equity | USD | 2 | 0001213900-25-045434 | Equity Components= Accumulated Other Comprehensive Income; | |||
0001213900-25-045434 | 20241231 | Stock Issued During Period Value New Issues | 6500.0000 | USD | 2 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001213900-25-045434 | 20241231 | Stock Issued During Period Value Reverse Stock Split | 146.0000 | USD | 2 | 0001213900-25-045434 | Equity Components= Common Stock; | ||
0001213900-25-045434 | 20241231 | Supplies | 25319.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Weighted Average Number Of Shares Outstanding Basic | 263473.0000 | shares | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Weighted Average Number Of Shares Outstanding Basic | 8402287.0000 | shares | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 100665223.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 132310506.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Common Stock Shares Outstanding | 2044363.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001213900-25-045434 | 20231231 | Depreciation Depletion And Amortization | 237631.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Depreciation Depletion And Amortization | 143348.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Due From Related Partie | USD | 2 | 0001213900-25-045434 | ||||
0001213900-25-045434 | 20240630 | Finite Lived Intangible Assets Net | 2377.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Gain Loss On Investments | USD | 2 | us-gaap/2024 | ||||
0001213900-25-045434 | 20231231 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -5193493.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Minority Interest | 795869.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Minority Interest | -19953.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Net Cash Provided By Used In Financing Activities | 11822082.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Net Cash Provided By Used In Financing Activities | 64662822.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Net Cash Provided By Used In Operating Activities | -322441.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Net Income Loss | USD | 2 | us-gaap/2024 | Equity Components= Statutory Reserve; | |||
0001213900-25-045434 | 20241231 | Net Income Loss | -7945649.0000 | USD | 2 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001213900-25-045434 | 20231231 | Nonoperating Income Expense | -881909.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Notes And Loans Receivable Net Current | USD | 0 | us-gaap/2024 | ||||
0001213900-25-045434 | 20231231 | Operating Expenses | 10886773.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Operating Lease Liability Current | 76419.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Operating Lease Liability Noncurrent | 1300195.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | USD | 2 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
0001213900-25-045434 | 20241231 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | USD | 2 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | |||
0001213900-25-045434 | 20240630 | Prepaid Expense And Other Assets Noncurrent | 60769864.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Revenue From Contract With Customer Including Assessed Tax | 16896126.0000 | USD | 2 | us-gaap/2024 | Product Or Service= Maintenance; | ||
0001213900-25-045434 | 20230630 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -7109254.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001213900-25-045434 | 20230630 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -3632766.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001213900-25-045434 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 664100.0000 | USD | 0 | us-gaap/2024 | Equity Components= Statutory Reserve; | ||
0001213900-25-045434 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 256877468.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001213900-25-045434 | 20231231 | Stock Issued During Period Value Conversion Of Convertible Securities | USD | 2 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | |||
0001213900-25-045434 | 20231231 | Stock Issued During Period Value Employee Benefit Plan | USD | 2 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | |||
0001213900-25-045434 | 20241231 | Stock Issued During Period Value Of Disposal | 5731103.0000 | USD | 2 | 0001213900-25-045434 | |||
0001213900-25-045434 | 20241231 | Stock Issued During Period Value Reverse Stock Split | USD | 2 | 0001213900-25-045434 | Equity Components= Noncontrolling Interest; | |||
0001213900-25-045434 | 20241231 | Taxes Payable Current | 31871.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Assets Current | 108769546.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20230630 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 71252380.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 74325312.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Common Stock Shares Outstanding | 2044363.0000 | shares | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Common Stock Shares Outstanding | 8690171.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001213900-25-045434 | 20241231 | Common Stock Value | 8690.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Comprehensive Income Net Of Tax | -4505504.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Cost Of Revenue | 700536.0000 | USD | 2 | us-gaap/2024 | Product Or Service= Educational Consulting Services; | ||
0001213900-25-045434 | 20231231 | Cost Of Revenue | 43241.0000 | USD | 2 | us-gaap/2024 | Product Or Service= Sales Of Pharmaceutical Products; | ||
0001213900-25-045434 | 20241231 | Cost Of Revenue | 20512460.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Cost Of Revenue | 7276240.0000 | USD | 2 | us-gaap/2024 | Product Or Service= Housekeeping; | ||
0001213900-25-045434 | 20241231 | Cost Of Revenue | 9896.0000 | USD | 2 | us-gaap/2024 | Product Or Service= Sales Of Pharmaceutical Products; | ||
0001213900-25-045434 | 20241231 | Equity Incentive Plan | USD | 2 | 0001213900-25-045434 | ||||
0001213900-25-045434 | 20241231 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -7945649.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Income Tax Expense Benefit | USD | 2 | us-gaap/2024 | ||||
0001213900-25-045434 | 20241231 | Inventory Net | USD | 0 | us-gaap/2024 | ||||
0001213900-25-045434 | 20241231 | Liabilities Noncurrent | 1697618.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Net Cash Provided By Used In Investing Activities | -31930000.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Net Income Loss | USD | 2 | us-gaap/2024 | Equity Components= Common Stock; | |||
0001213900-25-045434 | 20231231 | Net Income Loss | -5169892.0000 | USD | 2 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001213900-25-045434 | 20241231 | Net Income Loss | -7945649.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Net Income Loss | USD | 2 | us-gaap/2024 | Equity Components= Common Stock; | |||
0001213900-25-045434 | 20241231 | Operating Lease Right Of Use Asset Amortization Expense | 201952.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -856181.0000 | USD | 2 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001213900-25-045434 | 20240630 | Other Liabilities Current | 3154698.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | ||
0001213900-25-045434 | 20241231 | Other Liabilities Current | 1810037.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | ||
0001213900-25-045434 | 20241231 | Prepaid Expense And Other Assets Noncurrent | 60353162.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Profit Loss | -7945649.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Retained Earnings Accumulated Deficit | -24418619.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Revenue From Contract With Customer Including Assessed Tax | 957574.0000 | USD | 2 | us-gaap/2024 | Product Or Service= Educational Consulting Services; | ||
0001213900-25-045434 | 20231231 | Revenue From Contract With Customer Including Assessed Tax | 15151510.0000 | USD | 2 | us-gaap/2024 | Product Or Service= Maintenance; | ||
0001213900-25-045434 | 20241231 | Revenue From Contract With Customer Including Assessed Tax | 8609890.0000 | USD | 2 | us-gaap/2024 | Product Or Service= Housekeeping; | ||
0001213900-25-045434 | 20231231 | Selling And Marketing Expense | 8100026.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Selling And Marketing Expense | 8759104.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20230630 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 137808606.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20230630 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 147005748.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001213900-25-045434 | 20230630 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 54.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001213900-25-045434 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 149112541.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -6415316.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001213900-25-045434 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -8802658.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001213900-25-045434 | 20240630 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 163157776.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 2044.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | Retrospectively restated for effect of reverse stock splits on September 25, 2023, February 14, 2024 and September 24, 2024, and capital reduction on March 6, 2025. | |
0001213900-25-045434 | 20231231 | Stock Issued During Period Value Employee Benefit Plan | USD | 2 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
0001213900-25-045434 | 20231231 | Stock Issued During Period Value New Issues | USD | 2 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
0001213900-25-045434 | 20241231 | Stock Issued During Period Value Reverse Stock Split | USD | 2 | 0001213900-25-045434 | Equity Components= Retained Earnings; | |||
0001213900-25-045434 | 20241231 | Assets Current | 167019611.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Assets Noncurrent | 69042169.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Common Stock Shares Authorized | 100000000.0000 | shares | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Common Stock Shares Issued | 2044363.0000 | shares | 0 | us-gaap/2024 | Retrospectively restated for effect of reverse stock split on September 24, 2024 and capital reduction on March 6, 2025. | ||
0001213900-25-045434 | 20231231 | Due From Related Partie | -10688160.0000 | USD | 2 | 0001213900-25-045434 | |||
0001213900-25-045434 | 20231231 | Earnings Per Share Diluted | -19.6200 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Increase Decrease In Accounts Payable And Accrued Liabilities | -684230.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Increase Decrease In Accrued Income Taxes Payable | -6426.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Increase Decrease In Inventories | -18753.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Investment Income Investment Expense | 11509.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Liabilities And Stockholders Equity | 178718823.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Net Income Loss | -5193493.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Net Income Loss | -23601.0000 | USD | 2 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
0001213900-25-045434 | 20241231 | Net Income Loss | USD | 2 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | |||
0001213900-25-045434 | 20231231 | Payments To Acquire Loans Receivable | USD | 2 | us-gaap/2024 | ||||
0001213900-25-045434 | 20241231 | Restricted Cash Current | 69556.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Retained Earnings Accumulated Deficit | -23019895.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Revenue From Contract With Customer Including Assessed Tax | 190297.0000 | USD | 2 | us-gaap/2024 | Product Or Service= Sales Of Pharmaceutical Products; | ||
0001213900-25-045434 | 20240630 | Statutory Accounting Practices Statutory Capital And Surplus Balance | 664100.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 851174.0000 | USD | 0 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
0001213900-25-045434 | 20240630 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -7168199.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001213900-25-045434 | 20241231 | Stock Issued During Period Value Disposal Of Equity | USD | 2 | 0001213900-25-045434 | Equity Components= Common Stock; | |||
0001213900-25-045434 | 20241231 | Stock Issued During Period Value Disposal Of Equity | USD | 2 | 0001213900-25-045434 | Equity Components= Statutory Reserve; | |||
0001213900-25-045434 | 20241231 | Stock Issued During Period Value Reverse Stock Split | USD | 2 | 0001213900-25-045434 | ||||
0001213900-25-045434 | 20240630 | Taxes Payable Current | 38571.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Increase Decrease In Inventories | -22374.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Accounts Receivable Net Current | 17931.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Additional Paid In Capital Common Stock | 191883857.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Amortization Of Financing Costs | USD | 2 | us-gaap/2024 | ||||
0001213900-25-045434 | 20241231 | Asset Retirement Obligation Accretion Expense | USD | 2 | us-gaap/2024 | ||||
0001213900-25-045434 | 20240630 | Assets | 178718823.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Cash And Cash Equivalents At Carrying Value | 100665223.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Contract With Customer Liability Current | 499059.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Cost Of Revenue | 143370.0000 | USD | 2 | us-gaap/2024 | Product Or Service= Senior Care Services; | ||
0001213900-25-045434 | 20241231 | Earnings Per Share Diluted | -0.9500 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Income Taxes Paid | USD | 2 | us-gaap/2024 | ||||
0001213900-25-045434 | 20241231 | Increase Decrease In Accounts Receivable | -353314.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Increase Decrease In Contract With Customer Liability | 1483.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Increase Decrease In Operating Lease Liability | -99753.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Increase Decrease In Operating Lease Liability | -5891.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -3320800.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Increase Decrease In Prepaid Supplies | -11282.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Interest Paid Net | 11509.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Investment Income Investment Expense | 385524.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Issuance Of Shares To Directors And Consultants | USD | 2 | 0001213900-25-045434 | ||||
0001213900-25-045434 | 20241231 | Liabilities And Stockholders Equity | 236061780.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Liabilities Current | 9276856.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Nonoperating Income Expense | -2720875.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Notes And Loans Receivable Net Current | 31930000.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | USD | 2 | us-gaap/2024 | Equity Components= Common Stock; | |||
0001213900-25-045434 | 20241231 | Other Nonoperating Income Expense | -2887547.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Restricted Cash Current | 144855.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Revenue From Contract With Customer Including Assessed Tax | 2811223.0000 | USD | 2 | us-gaap/2024 | Product Or Service= Senior Care Services; | ||
0001213900-25-045434 | 20241231 | Revenue From Contract With Customer Including Assessed Tax | 502957.0000 | USD | 2 | us-gaap/2024 | Product Or Service= Educational Consulting Services; | ||
0001213900-25-045434 | 20241231 | Revenue From Contract With Customer Including Assessed Tax | 8407.0000 | USD | 2 | us-gaap/2024 | Product Or Service= Sales Of Pharmaceutical Products; | ||
0001213900-25-045434 | 20241231 | Revenue From Contract With Customer Including Assessed Tax | 354688.0000 | USD | 2 | us-gaap/2024 | Product Or Service= Senior Care Services; | ||
0001213900-25-045434 | 20240630 | Short Term Borrowings | 1375091.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Statutory Accounting Practices Statutory Capital And Surplus Balance | 664100.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Stockholders Equity | 162361907.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Stockholders Equity | 225107259.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 225087306.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Stock Issued1 | 3480679.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Stock Issued During Period Shares Employee Benefit Plan | 5200.0000 | shares | 2 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001213900-25-045434 | 20231231 | Stock Issued During Period Shares New Issues | 214634.0000 | shares | 2 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001213900-25-045434 | 20241231 | Stock Issued During Period Value Disposal Of Equity | -815822.0000 | USD | 2 | 0001213900-25-045434 | Equity Components= Noncontrolling Interest; | ||
0001213900-25-045434 | 20231231 | Stock Issued During Period Value Employee Benefit Plan | USD | 2 | us-gaap/2024 | Equity Components= Statutory Reserve; | |||
0001213900-25-045434 | 20231231 | Stock Issued During Period Value New Issues | 2146341.0000 | USD | 2 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001213900-25-045434 | 20241231 | Stock Issued During Period Value New Issues | USD | 2 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
0001213900-25-045434 | 20241231 | Stock Issued During Period Value New Issues | 64993757.0000 | USD | 2 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001213900-25-045434 | 20231231 | Stock Issued During Period Value Of Disposal | USD | 2 | 0001213900-25-045434 | ||||
0001213900-25-045434 | 20241231 | Stock Issued During Period Value Reverse Stock Split | USD | 2 | 0001213900-25-045434 | Equity Components= Statutory Reserve; | |||
0001213900-25-045434 | 20231231 | Interest Paid Net | 385524.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Inventory Net | 18751.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Assets | 236061780.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Assets Noncurrent | 69949277.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 2515346.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
0001213900-25-045434 | 20241231 | Common Stock Shares Issued | 8690171.0000 | shares | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Common Stock Value | 2044.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Cost Of Revenue | 6707480.0000 | USD | 2 | us-gaap/2024 | Product Or Service= Housekeeping; | ||
0001213900-25-045434 | 20231231 | Gain Loss On Sale Of Property Plant Equipment | -60910.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | General And Administrative Expense | 2325278.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Gross Profit | 5859608.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Increase Decrease In Accounts Receivable | -339061.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Increase Decrease In Accrued Income Taxes Payable | 5208.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Net Income Loss | USD | 2 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
0001213900-25-045434 | 20231231 | Net Income Loss | USD | 2 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
0001213900-25-045434 | 20241231 | Net Income Loss | USD | 2 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
0001213900-25-045434 | 20241231 | Net Income Loss | USD | 2 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
0001213900-25-045434 | 20241231 | Operating Expenses | 11084382.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Operating Lease Right Of Use Asset | 4795273.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Operating Lease Right Of Use Asset | 4559425.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | 693938.0000 | USD | 2 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001213900-25-045434 | 20231231 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | USD | 2 | us-gaap/2024 | Equity Components= Common Stock; | |||
0001213900-25-045434 | 20241231 | Prepaid Expense And Other Assets Current | 2735855.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Proceeds From Repayments Of Related Party Debt | -337435.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Provision For Other Credit Losses | USD | 2 | us-gaap/2024 | ||||
0001213900-25-045434 | 20230630 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 880724.0000 | USD | 0 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
0001213900-25-045434 | 20240630 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 664100.0000 | USD | 0 | us-gaap/2024 | Equity Components= Statutory Reserve; | ||
0001213900-25-045434 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -8024380.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001213900-25-045434 | 20241231 | Stock Issued1 | USD | 2 | us-gaap/2024 | ||||
0001213900-25-045434 | 20241231 | Stock Issued During Period Shares Reverse Stock Splits | 145808.0000 | shares | 2 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001213900-25-045434 | 20231231 | Stock Issued During Period Value Conversion Of Convertible Securities | 3145779.0000 | USD | 2 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001213900-25-045434 | 20231231 | Stock Issued During Period Value Conversion Of Convertible Securities | 334900.0000 | USD | 2 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001213900-25-045434 | 20231231 | Stock Issued During Period Value Conversion Of Convertible Securities | USD | 2 | us-gaap/2024 | Equity Components= Statutory Reserve; | |||
0001213900-25-045434 | 20231231 | Stock Issued During Period Value Employee Benefit Plan | 275340.0000 | USD | 2 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001213900-25-045434 | 20231231 | Stock Issued During Period Value Employee Benefit Plan | 52000.0000 | USD | 2 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001213900-25-045434 | 20240630 | Supplies | 969733.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Additional Paid In Capital Common Stock | 256877468.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Asset Retirement Obligation Accretion Expense | 623801.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 32410381.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
0001213900-25-045434 | 20240630 | Common Stock Shares Authorized | 100000000.0000 | shares | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20230630 | Common Stock Shares Outstanding | 54498.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001213900-25-045434 | 20231231 | Common Stock Shares Outstanding | 307822.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001213900-25-045434 | 20241231 | Comprehensive Income Net Of Tax | -8801830.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Cost Of Revenue | 572014.0000 | USD | 2 | us-gaap/2024 | Product Or Service= Educational Consulting Services; | ||
0001213900-25-045434 | 20241231 | Deferred Income Tax Liabilities Net | 397423.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 557586.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Gain Loss On Investments | -2880376.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Gain Loss On Sale Of Property Plant Equipment | USD | 2 | us-gaap/2024 | ||||
0001213900-25-045434 | 20241231 | Liabilities | 10974474.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Operating Income Loss | -4311584.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Operating Lease Right Of Use Asset Amortization Expense | 304163.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | USD | 2 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
0001213900-25-045434 | 20241231 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | USD | 2 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
0001213900-25-045434 | 20231231 | Other Nonoperating Income Expense | 274.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Prepaid Expense And Other Assets Current | 6506568.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20240630 | Property Plant And Equipment Net | 4381763.0000 | USD | 0 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Provision For Other Credit Losses | 93072.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Repayments Of Convertible Debt | 200000.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Revenue From Contract With Customer Including Assessed Tax | 26947183.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Short Term Borrowings | USD | 0 | us-gaap/2024 | ||||
0001213900-25-045434 | 20240630 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 795869.0000 | USD | 0 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
0001213900-25-045434 | 20240630 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -23019895.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001213900-25-045434 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 8690.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001213900-25-045434 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -19953.0000 | USD | 0 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
0001213900-25-045434 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -24418619.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001213900-25-045434 | 20241231 | Stock Issued During Period Shares New Issues | 6500000.0000 | shares | 2 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001213900-25-045434 | 20231231 | Stock Issued During Period Value Conversion Of Convertible Securities | USD | 2 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
0001213900-25-045434 | 20241231 | Stock Issued During Period Value Disposal Of Equity | USD | 2 | 0001213900-25-045434 | Equity Components= Additional Paid In Capital; | |||
0001213900-25-045434 | 20231231 | Stock Issued During Period Value Employee Benefit Plan | 327340.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Stock Issued During Period Value Employee Benefit Plan | USD | 2 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
0001213900-25-045434 | 20231231 | Stock Issued During Period Value New Issues | 12001420.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20231231 | Stock Issued During Period Value New Issues | USD | 2 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
0001213900-25-045434 | 20241231 | Stock Issued During Period Value New Issues | 65000257.0000 | USD | 2 | us-gaap/2024 | |||
0001213900-25-045434 | 20241231 | Stock Issued During Period Value New Issues | USD | 2 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
0001213900-25-045434 | 20241231 | Stock Issued During Period Value Reverse Stock Split | USD | 2 | 0001213900-25-045434 | Equity Components= Accumulated Other Comprehensive Income; | |||
0001213900-25-045434 | 20231231 | Weighted Average Number Of Diluted Shares Outstanding | 263479.0000 | shares | 2 | us-gaap/2024 | Retrospectively restated for effect of reverse stock split on February 14, 2024 and September 24, 2024. |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
ddate | The end date for the data value, rounded to the nearest month end. |
qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
uom | The unit of measure for the value. |
segments | Tags used to represent axis and member reporting. |
coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
---|---|---|---|---|---|---|---|---|
Increase Decrease In Accounts Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Increase Decrease In Other Noncurrent Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Noncurrent Assets | Amount of increase (decrease) in noncurrent assets classified as other. |
Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable and Accrued Liabilities, Current | Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Including Portion Attributable to Noncontrolling Interest | Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity. |
Supplies | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Supplies | Amount of consideration paid in advance for supplies that provide economic benefits within a future period of one year or the normal operating cycle, if longer. |
Taxes Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Taxes Payable, Current | Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
Gain Loss On Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Gain (Loss) on Investments | Amount of realized and unrealized gain (loss) on investment. |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
Increase Decrease In Contract With Customer Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Contract with Customer, Liability | Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable. |
Net Income Loss Attributable To Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Income (Loss) Attributable to Noncontrolling Interest | Amount of Net Income (Loss) attributable to noncontrolling interest. |
Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
Repayments Of Convertible Debt | us-gaap/2024 | 0 | 0 | monetary | D | C | Repayments of Convertible Debt | The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. |
Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
Stock Issued1 | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued | The fair value of stock issued in noncash financing activities. |
Due From Related Partie | 0001213900-25-045434 | 1 | 0 | monetary | D | D | Due From Related Partie | Represent the amount of due from related parties. |
Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
Accounts Receivable Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
Provision For Other Credit Losses | us-gaap/2024 | 0 | 0 | monetary | D | D | Provision for Other Credit Losses | Amount of expense related to credit loss from transactions other than loan and lease transactions. |
Restricted Cash Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Cash, Current | Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. |
Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
Stock Issued During Period Value Conversion Of Convertible Securities | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Conversion of Convertible Securities | The gross value of stock issued during the period upon the conversion of convertible securities. |
Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | D | D | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations | Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Gross Profit | us-gaap/2024 | 0 | 0 | monetary | D | C | Gross Profit | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
Income Taxes Paid | us-gaap/2024 | 0 | 0 | monetary | D | C | Income Taxes Paid | Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax. |
Cost Of Revenue | us-gaap/2024 | 0 | 0 | monetary | D | D | Cost of Revenue | The aggregate cost of goods produced and sold and services rendered during the reporting period. |
Selling And Marketing Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Selling and Marketing Expense | The aggregate total amount of expenses directly related to the marketing or selling of products or services. |
Stock Issued During Period Shares Conversion Of Convertible Securities | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Conversion of Convertible Securities | Number of shares issued during the period as a result of the conversion of convertible securities. | |
Stock Issued During Period Shares Reverse Stock Splits | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Reverse Stock Splits | Reduction in the number of shares during the period as a result of a reverse stock split. | |
Issuance Of Shares To Directors And Consultants | 0001213900-25-045434 | 1 | 0 | monetary | D | C | Issuance Of Shares To Directors And Consultants | Issue of shares to directors and consultants for consideartion other than cash. |
Depreciation Depletion And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. |
Increase Decrease In Accrued Income Taxes Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Income Taxes Payable | The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction. |
Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. |
Prepaid Expense And Other Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Noncurrent | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer. |
Stock Issued During Period Shares Employee Benefit Plan | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Employee Benefit Plan | Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan. | |
Finite Lived Intangible Assets Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Finite-Lived Intangible Assets, Net | Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. |
Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
Increase Decrease In Inventories | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Inventories | The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
Increase Decrease In Prepaid Supplies | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Supplies | Amount of increase (decrease) of consideration paid in advance for supplies that provide economic benefits in future periods. |
Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
Other Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Current | Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. |
Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
Statutory Accounting Practices Statutory Capital And Surplus Balance | us-gaap/2024 | 0 | 0 | monetary | I | C | Statutory Accounting Practices, Statutory Capital and Surplus, Balance | The amount of statutory capital and surplus (stockholders' equity) as of the balance sheet date using prescribed or permitted statutory accounting practices (rather than GAAP, if different) of the state or country. |
Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Noncurrent | Amount of obligation due after one year or beyond the normal operating cycle, if longer. |
Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
Short Term Borrowings | us-gaap/2024 | 0 | 0 | monetary | I | C | Short-Term Debt | Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer. |
Proceeds From Repayments Of Related Party Debt | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from (Repayments of) Related Party Debt | Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts. |
Stock Issued During Period Value Reverse Stock Split | 0001213900-25-045434 | 1 | 0 | monetary | D | C | Stock Issued During Period Value Reverse Stock Split | Represents the value of stock issued under reverse stock split. |
Amortization Of Financing Costs | us-gaap/2024 | 0 | 0 | monetary | D | D | Amortization of Debt Issuance Costs | Amount of amortization expense attributable to debt issuance costs. |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
Inventory Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Inventory, Net | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. |
Stock Issued During Period Shares New Issues | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
Additional Paid In Capital Common Stock | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
Equity Incentive Plan | 0001213900-25-045434 | 1 | 0 | monetary | D | D | Equity Incentive Plan | Represent the amount of equity incentive plan. |
Stock Issued During Period Value Of Disposal | 0001213900-25-045434 | 1 | 0 | monetary | D | C | Stock Issued During Period Value Of Disposal | The amount of disposal of ownership in fuzhou fumao. |
Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Noncurrent | Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. |
Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
Deferred Income Tax Liabilities Net | us-gaap/2024 | 0 | 0 | monetary | I | C | Deferred Income Tax Liabilities, Net | Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting. |
Gain Loss On Sale Of Property Plant Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Gain (Loss) on Disposition of Property Plant Equipment | Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property. |
Increase Decrease In Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Lease, Right-of-Use Asset, Periodic Reduction | Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease. |
Asset Retirement Obligation Accretion Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Asset Retirement Obligation, Accretion Expense | Amount of accretion expense recognized during the period that is associated with an asset retirement obligation. Accretion expense measures and incorporates changes due to the passage of time into the carrying amount of the liability. |
Contract With Customer Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Contract with Customer, Liability, Current | Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current. |
Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
Investment Income Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Investment Income, Interest | Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. |
Investment Income Investment Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Investment Income, Investment Expense | Amount of expenses related to the generation of investment income. |
Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
Other Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
Proceeds From Issuance Of Common Stock | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. |
Revenue From Contract With Customer Including Assessed Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenue from Contract with Customer, Including Assessed Tax | Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. |
Stock Issued During Period Value New Issues | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
Minority Interest | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Noncontrolling Interest | Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity. |
Stock Issued During Period Value Disposal Of Equity | 0001213900-25-045434 | 1 | 0 | monetary | D | C | Stock Issued During Period Value Disposal Of Equity | Represents the value of stock issued under disposal of equity. |
Notes And Loans Receivable Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Financing Receivable, after Allowance for Credit Loss, Current | Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease. |
Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
Payments To Acquire Loans Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Loans Receivable | The cash outflow for the purchase of loan receivable arising from the financing of goods and services. |
Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
Stock Issued During Period Value Employee Benefit Plan | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Employee Benefit Plan | Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan. |
Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
Field Name | Field Description |
---|---|
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
abstract | 1 if the tag is not used to represent a numeric fact. |
datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
---|---|---|---|---|---|---|---|---|---|
0001213900-25-045434 | 2 | 7 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
0001213900-25-045434 | 2 | 8 | BS | 0 | H | Restricted Cash Current | us-gaap/2024 | Restricted cash | 0 |
0001213900-25-045434 | 2 | 9 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2024 | Accounts receivable | 0 |
0001213900-25-045434 | 2 | 10 | BS | 0 | H | Supplies | us-gaap/2024 | Advances to suppliers | 0 |
0001213900-25-045434 | 2 | 11 | BS | 0 | H | Inventory Net | us-gaap/2024 | Inventories | 0 |
0001213900-25-045434 | 2 | 12 | BS | 0 | H | Notes And Loans Receivable Net Current | us-gaap/2024 | Loan receivable | 0 |
0001213900-25-045434 | 2 | 13 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepayment, receivables and other current assets | 0 |
0001213900-25-045434 | 2 | 14 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
0001213900-25-045434 | 2 | 16 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property, plant and equipment, net | 0 |
0001213900-25-045434 | 2 | 17 | BS | 0 | H | Finite Lived Intangible Assets Net | us-gaap/2024 | Intangible assets, net | 0 |
0001213900-25-045434 | 2 | 18 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease - right-of-use assets, net | 0 |
0001213900-25-045434 | 2 | 19 | BS | 0 | H | Prepaid Expense And Other Assets Noncurrent | us-gaap/2024 | Long-term deposits and other non-current assets | 0 |
0001213900-25-045434 | 2 | 20 | BS | 0 | H | Assets Noncurrent | us-gaap/2024 | Total non-current assets | 0 |
0001213900-25-045434 | 2 | 21 | BS | 0 | H | Assets | us-gaap/2024 | TOTAL ASSETS | 0 |
0001213900-25-045434 | 2 | 23 | BS | 0 | H | Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | Accounts payable and accrued expenses | 0 |
0001213900-25-045434 | 2 | 24 | BS | 0 | H | Contract With Customer Liability Current | us-gaap/2024 | Advances from customers | 0 |
0001213900-25-045434 | 2 | 25 | BS | 0 | H | Taxes Payable Current | us-gaap/2024 | Taxes payable | 0 |
0001213900-25-045434 | 2 | 26 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Current maturities of operating lease liabilities | 0 |
0001213900-25-045434 | 2 | 27 | BS | 0 | H | Other Liabilities Current | us-gaap/2024 | Due to related parties | 0 |
0001213900-25-045434 | 2 | 28 | BS | 0 | H | Short Term Borrowings | us-gaap/2024 | Short-term loan | 0 |
0001213900-25-045434 | 2 | 29 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
0001213900-25-045434 | 2 | 31 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Long-term portion of operating lease liabilities | 0 |
0001213900-25-045434 | 2 | 32 | BS | 0 | H | Deferred Income Tax Liabilities Net | us-gaap/2024 | Deferred tax liabilities, net | 0 |
0001213900-25-045434 | 2 | 33 | BS | 0 | H | Liabilities Noncurrent | us-gaap/2024 | Total non-current liabilities | 0 |
0001213900-25-045434 | 2 | 34 | BS | 0 | H | Liabilities | us-gaap/2024 | TOTAL LIABILITIES | 0 |
0001213900-25-045434 | 2 | 35 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies (Note 18) | 0 |
0001213900-25-045434 | 2 | 37 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Ordinary shares, $0.001 par value, 100,000,000 shares authorized; 8,690,171 shares and 2,044,363 issued and outstanding as of December 31, 2024 and June 30, 2024) | 0 |
0001213900-25-045434 | 2 | 38 | BS | 0 | H | Additional Paid In Capital Common Stock | us-gaap/2024 | Additional paid-in capital | 0 |
0001213900-25-045434 | 2 | 39 | BS | 0 | H | Statutory Accounting Practices Statutory Capital And Surplus Balance | us-gaap/2024 | Statutory reserve | 0 |
0001213900-25-045434 | 2 | 40 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulate deficits | 0 |
0001213900-25-045434 | 2 | 41 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive loss | 0 |
0001213900-25-045434 | 2 | 42 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total equity attributable to shareholders | 0 |
0001213900-25-045434 | 2 | 43 | BS | 0 | H | Minority Interest | us-gaap/2024 | Non-controlling interest | 0 |
0001213900-25-045434 | 2 | 44 | BS | 0 | H | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2024 | TOTAL SHAREHOLDERS EQUITY | 0 |
0001213900-25-045434 | 2 | 45 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | TOTAL LIABILITIES AND SHAREHOLDERS EQUITY | 0 |
0001213900-25-045434 | 3 | 1 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Ordinary shares, par value (in Dollars per share) | 0 |
0001213900-25-045434 | 3 | 2 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Ordinary shares, shares authorized | 0 |
0001213900-25-045434 | 3 | 3 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Ordinary shares, shares issued | 0 |
0001213900-25-045434 | 3 | 4 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Ordinary shares, shares outstanding | 0 |
0001213900-25-045434 | 4 | 11 | IS | 0 | H | Revenue From Contract With Customer Including Assessed Tax | us-gaap/2024 | Total revenues | 0 |
0001213900-25-045434 | 4 | 13 | IS | 0 | H | Cost Of Revenue | us-gaap/2024 | Total cost of revenues | 0 |
0001213900-25-045434 | 4 | 14 | IS | 0 | H | Gross Profit | us-gaap/2024 | Gross profit | 0 |
0001213900-25-045434 | 4 | 16 | IS | 0 | H | Selling And Marketing Expense | us-gaap/2024 | Sales and marketing expenses | 0 |
0001213900-25-045434 | 4 | 17 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative expenses | 0 |
0001213900-25-045434 | 4 | 18 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
0001213900-25-045434 | 4 | 19 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
0001213900-25-045434 | 4 | 21 | IS | 0 | H | Investment Income Interest | us-gaap/2024 | Interest income | 0 |
0001213900-25-045434 | 4 | 22 | IS | 0 | H | Investment Income Investment Expense | us-gaap/2024 | Interest expenses | 1 |
0001213900-25-045434 | 4 | 23 | IS | 0 | H | Amortization Of Financing Costs | us-gaap/2024 | Amortization of financing cost | 1 |
0001213900-25-045434 | 4 | 24 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2024 | Other (expenses) income, net | 0 |
0001213900-25-045434 | 4 | 25 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Total other expenses, net | 0 |
0001213900-25-045434 | 4 | 26 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Loss before income taxes | 0 |
0001213900-25-045434 | 4 | 27 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Income tax expense | 1 |
0001213900-25-045434 | 4 | 28 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
0001213900-25-045434 | 4 | 30 | IS | 0 | H | Profit Loss | us-gaap/2024 | Net loss attributable to the Companys shareholders | 0 |
0001213900-25-045434 | 4 | 31 | IS | 0 | H | Net Income Loss Attributable To Noncontrolling Interest | us-gaap/2024 | Net loss attributable to non-controlling interests | 1 |
0001213900-25-045434 | 4 | 32 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
0001213900-25-045434 | 4 | 34 | IS | 0 | H | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | Foreign currency translation adjustment, net of nil tax | 0 |
0001213900-25-045434 | 4 | 35 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Total comprehensive loss | 0 |
0001213900-25-045434 | 4 | 36 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net loss per ordinary share - basic (in Dollars per share) | 0 |
0001213900-25-045434 | 4 | 37 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per ordinary share - diluted (in Dollars per share) | 0 |
0001213900-25-045434 | 4 | 38 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted average number of ordinary shares outstanding - basic (in Shares) | 0 |
0001213900-25-045434 | 4 | 39 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted average number of ordinary shares outstanding - diluted (in Shares) | 0 |
0001213900-25-045434 | 5 | 11 | EQ | 0 | H | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2024 | Balance | 0 |
0001213900-25-045434 | 5 | 12 | EQ | 0 | H | Common Stock Shares Outstanding | us-gaap/2024 | Balance (in Shares) | 0 |
0001213900-25-045434 | 5 | 13 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
0001213900-25-045434 | 5 | 14 | EQ | 0 | H | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | Foreign currency translation adjustment | 0 |
0001213900-25-045434 | 5 | 15 | EQ | 0 | H | Stock Issued During Period Value Disposal Of Equity | 0001213900-25-045434 | Disposal of equity in Zhongrun | 0 |
0001213900-25-045434 | 5 | 16 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2024 | Shares issued to investors | 0 |
0001213900-25-045434 | 5 | 17 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Shares issued to investors (in Shares) | 0 |
0001213900-25-045434 | 5 | 18 | EQ | 0 | H | Stock Issued During Period Value Reverse Stock Split | 0001213900-25-045434 | Reverse stock split | 0 |
0001213900-25-045434 | 5 | 19 | EQ | 0 | H | Stock Issued During Period Shares Reverse Stock Splits | us-gaap/2024 | Reverse stock split (in Shares) | 0 |
0001213900-25-045434 | 5 | 20 | EQ | 0 | H | Stock Issued During Period Value Employee Benefit Plan | us-gaap/2024 | Shares issued under equity incentive plan | 0 |
0001213900-25-045434 | 5 | 21 | EQ | 0 | H | Stock Issued During Period Shares Employee Benefit Plan | us-gaap/2024 | Shares issued under equity incentive plan (in Shares) | 0 |
0001213900-25-045434 | 5 | 22 | EQ | 0 | H | Stock Issued During Period Value Conversion Of Convertible Securities | us-gaap/2024 | Shares issued for conversion of convertible notes | 0 |
0001213900-25-045434 | 5 | 23 | EQ | 0 | H | Stock Issued During Period Shares Conversion Of Convertible Securities | us-gaap/2024 | Shares issued for conversion of convertible notes (in Shares) | 0 |
0001213900-25-045434 | 5 | 24 | EQ | 0 | H | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2024 | Balance | 0 |
0001213900-25-045434 | 5 | 25 | EQ | 0 | H | Common Stock Shares Outstanding | us-gaap/2024 | Balance (in Shares) | 0 |
0001213900-25-045434 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
0001213900-25-045434 | 6 | 3 | CF | 0 | H | Investment Income Investment Expense | us-gaap/2024 | Interest expense | 0 |
0001213900-25-045434 | 6 | 4 | CF | 0 | H | Provision For Other Credit Losses | us-gaap/2024 | Estimated credit loss | 0 |
0001213900-25-045434 | 6 | 5 | CF | 0 | H | Depreciation Depletion And Amortization | us-gaap/2024 | Depreciation and amortization | 0 |
0001213900-25-045434 | 6 | 6 | CF | 0 | H | Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2024 | Amortization of right-of-use assets | 0 |
0001213900-25-045434 | 6 | 7 | CF | 0 | H | Asset Retirement Obligation Accretion Expense | us-gaap/2024 | Convertible note - Amortization of financing cost | 0 |
0001213900-25-045434 | 6 | 8 | CF | 0 | H | Equity Incentive Plan | 0001213900-25-045434 | Equity incentive plan | 0 |
0001213900-25-045434 | 6 | 9 | CF | 0 | H | Gain Loss On Sale Of Property Plant Equipment | us-gaap/2024 | Written off of property, plant and equipment | 1 |
0001213900-25-045434 | 6 | 10 | CF | 0 | H | Gain Loss On Investments | us-gaap/2024 | Investment loss from disposal of equity in Zhongrun | 1 |
0001213900-25-045434 | 6 | 12 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2024 | Accounts receivables | 1 |
0001213900-25-045434 | 6 | 13 | CF | 0 | H | Increase Decrease In Prepaid Supplies | us-gaap/2024 | Advance to suppliers | 1 |
0001213900-25-045434 | 6 | 14 | CF | 0 | H | Increase Decrease In Inventories | us-gaap/2024 | Inventories | 1 |
0001213900-25-045434 | 6 | 15 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepayment, receivables and other current assets | 1 |
0001213900-25-045434 | 6 | 16 | CF | 0 | H | Increase Decrease In Other Noncurrent Assets | us-gaap/2024 | Long-term deposits and other non-current assets | 1 |
0001213900-25-045434 | 6 | 17 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accounts payable and accrued expenses | 0 |
0001213900-25-045434 | 6 | 18 | CF | 0 | H | Increase Decrease In Contract With Customer Liability | us-gaap/2024 | Advance from customers | 0 |
0001213900-25-045434 | 6 | 19 | CF | 0 | H | Increase Decrease In Accrued Income Taxes Payable | us-gaap/2024 | Taxes payable | 0 |
0001213900-25-045434 | 6 | 20 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2024 | Operating lease liabilities | 0 |
0001213900-25-045434 | 6 | 21 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash (used in) provided by operating activities | 0 |
0001213900-25-045434 | 6 | 23 | CF | 0 | H | Payments To Acquire Loans Receivable | us-gaap/2024 | Loan receivable | 1 |
0001213900-25-045434 | 6 | 24 | CF | 0 | H | Due From Related Partie | 0001213900-25-045434 | Due from related parties | 0 |
0001213900-25-045434 | 6 | 25 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash used in investing activities | 0 |
0001213900-25-045434 | 6 | 27 | CF | 0 | H | Proceeds From Issuance Of Common Stock | us-gaap/2024 | Proceeds from share issuance | 0 |
0001213900-25-045434 | 6 | 28 | CF | 0 | H | Repayments Of Convertible Debt | us-gaap/2024 | Repayment convertible note | 1 |
0001213900-25-045434 | 6 | 29 | CF | 0 | H | Proceeds From Repayments Of Related Party Debt | us-gaap/2024 | (Payment to) Collection from related parties | 0 |
0001213900-25-045434 | 6 | 30 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
0001213900-25-045434 | 6 | 31 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | Net increase in cash and cash equivalents | 0 |
0001213900-25-045434 | 6 | 32 | CF | 0 | H | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Effects of currency translation | 0 |
0001213900-25-045434 | 6 | 33 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents at beginning of period | 0 |
0001213900-25-045434 | 6 | 34 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents at end of period | 0 |
0001213900-25-045434 | 6 | 36 | CF | 0 | H | Income Taxes Paid | us-gaap/2024 | Income taxes paid | 0 |
0001213900-25-045434 | 6 | 37 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Interest paid | 0 |
0001213900-25-045434 | 6 | 39 | CF | 0 | H | Stock Issued During Period Value Of Disposal | 0001213900-25-045434 | Disposal of equity in Zhongrun | 0 |
0001213900-25-045434 | 6 | 40 | CF | 0 | H | Stock Issued1 | us-gaap/2024 | Issuance of shares for convertible note principal and interest settlement | 0 |
0001213900-25-045434 | 6 | 41 | CF | 0 | H | Issuance Of Shares To Directors And Consultants | 0001213900-25-045434 | Issuance of shares to directors and consultants | 0 |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
stmt | The financial statement location to which the value of the “report” field pertains. |
inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
tag | The tag chosen by the filer for this line item. |
version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
plabel | The text presented on the line item, also known as a “preferred” label. |
negating | Flag to indicate whether the plabel is negating. |